Skip to Main Content

Paper Details

Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing.
Journal of Medicinal Chemistry
66
2018
(, ( R)- and ( S)-ND-336, -8, DFUs, Diabetic Foot Ulcers, Diabetic foot ulcers, Humans, MMP-8, MMP-9, MMPs, Matrix Metalloproteinase-9, becaplermin, diabetic, diabetic wound, diabetic wounds, human, humans, matrix metalloproteinase (MMP)-9, mice, wound
Author NameAffiliation
Dac-Trung NguyenUniversity of Notre Dame
Matthew M ChampionUniversity of Notre Dame
  • 1 - 2

Datasets

Release 1.2